1110 Main Street Williamtic, CT 06226 (860) 617-8265.

Slides:



Advertisements
Similar presentations
Daliah Heller, PhD, MPH Assistant Commissioner
Advertisements

Cindy Powers Magrini, PharmD, BCPS
Prevention Conference October 30 th, 2014 Help Save Lives in the Commonwealth Join The Massachusetts 911 Good Samaritan Campaign.
Suicide Prevention – a partnership approach Mark Smith Head of Suicide Prevention and Mental Health.
Expedited Partner Therapy (EPT) in NM Bruce G. Trigg, MD Medical Director, STD Program Regions 1 and 3 New Mexico Department of Health.
Medicaid and the Deficit Reduction Act (DRA) of 2005 Dan Walter Sr. Health Policy Analyst AAP Division of State Government Affairs AAP National Conference.
Deaths Avoided With Naloxone What is Naloxone? Naloxone commonly known as Narcan is a medication that can reverse and overdose caused by an opioid drug.
OVERDOSE PREVENTION PROGRAM Shawn Woods Manager, CDC Department Representing: CDC Department CDIP Department.
Preventing Prescription Drug Abuse: Laws and Legislation Hollie Hendrikson, MSc Policy Specialist, Health Program.
DBHDS Vision: A life of possibilities for all Virginians Treatment for Opioid Addiction Public Community Treatment in Virginia Virginia Heroin and Prescription.
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015.
MANDATED REPORTING, Adjunct Professor Monica Bogucki Copyright 2013 Monica Bogucki.
Law as Barrier to and Facilitator of Opioid Overdose Prevention Corey Davis, JD, MSPH Cross-System Collaboration to Respond to the Prescription Drug Epidemic.
Bylaw on drug demand reduction in Serbia. Bylaw(s) - principles  should be based on existing law(s)  should complement existing laws  should not be.
Opioid Safety Phillip Coffin, MD, MIA Director of Substance Use Research San Francisco Dept. of Public Health Assistant Clinical Professor University of.
New Employee Orientation
New Jersey School Districts By: Josefa Olson. Montclair Public Schools  Comprehensive community public school district that serves students in Kindergarten.
John M. Sharbaugh, CEO Texas Society of CPAs.  Texas legislature passed “Peer Assistance Programs” statute in 1989 (Chapter 467) to promote the creation.
Fraud, Waste & Abuse DEFICIT REDUCTION ACT OF 2005 Presented by: MARCH Vision Care, 2013.
OVERDOSE FATALITY REVIEW A THOUGHTFUL APPROACH TO PAIN MANAGEMENT MAY 29-30, 2015 Erin Haas Overdose Prevention Local Programs Manager.
Strategies for Incorporating OD Prevention Into Your Work Eliza Wheeler Drug Overdose Prevention & Education (DOPE) Project Harm Reduction Coalition
Section 4.3 Depression and Suicide Slide 1 of 20.
Naloxone (Narcan) A true opioid overdose antidote.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
Prescription Drug Monitoring Programs: Analysis of State Level Usage Requirements Matthew Penn, JD, Carla Chen, JD Director, Public Health Law Program.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 1.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 2/23/20151.
Medical Assistance Program Oversight Council June 13, 2014.
Single Convention on Narcotic Drugs Establishes a regulatory system for narcotic drugs government authorization is required for participation in the trade.
Mindtrap.
Naloxone: Cost, Logistics, and Supply Issues Community Pharmacy Perspective Krystalyn Weaver, PharmD National Alliance of State Pharmacy Associations.
Trends in Opioid Use and Overdose in BC: Making the case for greater availability of Take Home Naloxone programs Ashraf Amlani Harm Reduction Epidemiologist.
Medicines and Drugs.  The Role of Medicine  Medicines- drugs that are used to treat or prevent disease or other conditions  Drugs- substances other.
MANDATED REPORTING, Adjunct Professor Monica Bogucki Copyright 2011 Monica Bogucki.
Maryland’s “Good Samaritan” Law Annotated Code of Maryland, Criminal Procedure §1-210 Effective October 1, 2015 September
1 December 8, 2015 Crista M. Taylor, LCSW-C Director, Information, Planning and Development Adrienne Breidenstine, MSW Director of Opioid Overdose Prevention.
Naloxone nasal spray in Norway Thomas Clausen Professor (Dr. med) 5. November 2015.
NALOXONE Presented by The RASE Project. Scope Of The Problem Opiate overdose is a major public health problem in the United States. Overdoses have increased.
Naloxone: Prescribing and Dispensing
Barnstable County Regional Substance Abuse Council Updated October 2015 Barnstable County Department of Human Services |
1 The Center for Health and Health Care in Schools Improving Safety and Quality in Medication Management in Schools Julia Graham Lear, PhD, Director, Center.
Bystander Naloxone Training Saves Lives. Death rates are spiraling out of control--for both prescription opioids and heroin! Graphic: Nytimes.com.
0 Ethics Lecture The Impaired Physician. ACADEMY OF OPHTHALMOLOGY Disclosure  The speaker has no financial interest in the subject.
Georgia’s New and Improved PDMP. Greg Reybold, J.D. VP Public Policy & Association Counsel Georgia Pharmacy Association.
HOPE Agenda Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN – ASSEMBLY DISTRICT 89.
Incidental Medical Services (IMS) Department of
Pharmacist Role in Naloxone Prescribing
or you can use Text Voting by texting ”nmpha” to 22333
MODULE 3 Harm reduction advocacy
State Targeted Response to Opioid Crisis
Understanding a Harm Reduction Approach to Drug Interventions
Opioid Addiction in Tennessee
Nebraska Prescription Drug Overdose Prevention Program Efforts
Medication-Assisted Therapy at Coleman Profession Services
An overdose Reduction PlaN
Narcan & Michigan Public Libraries
Henry L. Dorkin, MD, FAAP President, Massachusetts Medical Society
Opioid Crisis A Call to ACTION
Community Researcher?? Patient Researcher?? Patient Researcher??
MDHHS Response to the Opioid Crisis
Opiate Roundtable March 29, 2018 Karen Burgess, MD
Prescription Drug Monitoring Program
West Virginia Medicaid Summit
Prescription Drug Monitoring Program
Naloxone in North Carolina
Act Naloxone Availability
CRC Breakfast Series July 10, 2018 Julie Cammarata, CRC Administrator
CommUNITY Recovery Partnership
Strategic Initiatives to Address Opioid Overdose & Addiction
Human Dignity and Harm Reduction
Presentation transcript:

1110 Main Street Williamtic, CT (860)

USING CIVIL DISOBEDIENCE TO ESTABLISH A PUBLIC HEALTH NORM; AN OVERVIEW OF A TRANSITIONING MODEL FOR NALOXONE DISTRIBUTION IN CT Chris Heneghan, Thomas McNally, Mike McNally, Windham Harm Reduction Coalition Inc., (2012).

PA AN ACT CONCERNING TREATMENT FOR A DRUG OVERDOSE Section 1. Section 17a-714a of the general statutes is repealed and the following is substituted in lieu thereof (Effective October 1, 2012): A licensed health care professional who is permitted by law to prescribe an opioid antagonist may, if acting with reasonable care, prescribe, dispense or administer an opioid antagonist [to a drug user in need of such intervention] to treat or prevent a drug overdose without being liable for damages [to such person] in a civil action or subject to criminal prosecution for prescribing, dispensing or administering such opioid antagonist or for any subsequent use of such opioid antagonist. For purposes of this section, “opioid antagonist” means naloxone hydrochloride or any other similarly acting and equally safe drug approved by the federal Food and Drug Administration for the treatment of drug overdose. Section 2. (Effective October 1, 2012) Not later than January 15, 2013, the Commissioner of Mental Health and Addiction Services shall report, in accordance with the provisions of section 11-4a of the general statutes, to the joint standing committee of the General Assembly having cognizance of matters relating to public health concerning the number of opioid antagonist prescriptions issued under programs administered by the Department of Mental Health and Addiction Services to persons other than drug users for self-administration of the opioid antagonist, in accordance with section 17a-714a of the general statutes, as amended by this act.

PUBLIC ACT WHAT WILL IT DO? Effective in Connecticut as of October 1, 2012, prescribers can prescribe, dispense or administer Naloxone (Narcan) to persons other than drug users to treat or prevent a drug overdose.

PUBLIC ACT WHAT IT DOES NOT DO? No Protection from Civil Liability for Lay administration No Protection from Criminal Liability for Lay Administration No Protection from Unauthorized Practice of Medicine for Lay Administration. No Protection from Criminal Liability for the Possession of Naloxone w/o a Prescription No State Program Created to Prevent OD Deaths through Naloxone Prescription Access. No funding allocation for DMAHS Behavioral Health Programs or SEPs No 3 rd Party Prescription Coverage (Davis, The Network for Public Health Law 2012.)

WHAT IS CIVIL DISOBEDIENCE? The concept of civil disobedience has deep roots in American political, social and cultural history. (Loesch,1991) Acts of civil disobedience highlight injustices in society. Civil disobedience is one means of taking action to bring about change. Civil Disobedience is conscious and public statement about the injustice of the status quo. The degree of attention society give to such acts may vary but one purpose of civil disobedience is to demonstrate to society and the governing bodies that oversee it that the existing laws are unjust. In order for physicians and other health care providers to legally pursue civil disobedience, they must be willing to accept the consequences associated with their actions. (Lazarini 2000) What is the injustice? Current legislation maintains existing barriers to Naloxone Access for SEP members who do not have a PCP, or do not have a clinical relationship CT DMHAS funded behavioral health programs… No legal protection for lay distribution or administration under current Connecticut Law…

THE PROBLEM OF DRUG OVERDOSES IN CT Leading cause of adult injury death, more than deaths due to MVA, fire, firearms combined For every fatal overdose that occurs in a community there are seven non- fatal overdoses. TC Green, LE Grau, HW Carver, M Kinzly, R Heimer. Epidemiologic and geographic trends in fatal opioid intoxications in Connecticut, USA: Drug and Alcohol Dependence (2011).

A Transitional Model Our Philosophy WHRC’s transitional model aims to strike a balance between what we as Harm Reductionist believe the ideal norm for public health practice should be, and the existing norm for public health practice in CT. We seek to strengthen existing community partnerships and are working to build a state wide prescribing network in collaboration with DMHAS at community based health centers. We contribute to and acknowledge the importance of legislative work on this issue, but also believe that to effectively fight this epidemic we can not wait for the legislative balance to tip into the arena of ethical public health practice. It may never happen. Thought the state may condone prohibitive policy responsible for the erroneous deprivation of life of individuals involved with drugs we as Harm Reductionists will not!

WHO ADMINISTERED NALOXONE

Number of ODs in Relation to Doses of Naloxone Given Naloxone was administered in only 34% of all reported opioid overdoses witnessed by respondents between March 2012, and October 2012.

TownReported ODs Willimantic 41 Coventry 5 Lebanon 5 Plainfield 3 Hampton 1 NUMBER OF ODs WITNESSED BY RESPONDENTS BY TOWN March 2012 – April 2012 It is estimated that 5 of these 55 reported overdoses were fatal. Participants reported 19 successful reversals using Naloxone received from WHRC.